Carles Monterrubio

Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

J. Mora, C. Lavarino, A. Carcaboso, 2015, Pharmaceutical Research.

Targeted drug distribution in tumor extracellular fluid of GD2‐expressing neuroblastoma patient‐derived xenografts using SN‐38‐loaded nanoparticles conjugated to the monoclonal antibody 3F8

J. Mora, C. Lavarino, N. Cheung, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

J. Mora, C. Lavarino, A. Carcaboso, 2021, The journal of pathology. Clinical research.

Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy

J. Arribas, C. Costa, H. Harada, 2018, Proceedings of the National Academy of Sciences.

Glucosylated nanomicelles target glucose‐avid pediatric patient‐derived sarcomas

J. Mora, A. Carcaboso, A. Sosnik, 2018, Journal of controlled release : official journal of the Controlled Release Society.

SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery.

J. Mora, J. Tornero, A. Carcaboso, 2016, Biomaterials.

Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.

J. Mora, C. Lavarino, C. de Torres, 2016, Cancer letters.

Tissue Compatibility of SN‐38‐Loaded Anticancer Nanofiber Matrices

J. Mora, J. Tornero, Francesc Cano, 2018, Advanced healthcare materials.

Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution.

J. Mora, E. de Álava, C. Lavarino, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Prognostic value of xenograft engraftment in patients with metastatic high‐risk neuroblastoma

J. Mora, C. Lavarino, A. Carcaboso, 2023, Pediatric blood & cancer.